Biotech · Public company · South San Francisco, CA, US
Oric Pharmaceuticals, Inc.
Ticker ORIC · SEC CIK 0001796280
Track this companyFree. Adds Oric Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials74 recruiting or active
Pipeline programs19From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline19
- DarolutamidePhase 3 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 3 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- RinzimetostatPhase 3 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Chemotherapy drugPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ORIC-114Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Abiraterone acetate (Zytiga®) 250 mg or 500 mg tabletsPhase 1 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Apalutamide (Erleada™) 60 mg or 240 mg tabletsPhase 1 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Darolutamide (Nubeqa®) 300 mg tabletsPhase 1 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Enzalutamide (Xtandi®) 40 mg capsules or 40 mg and 80 mg tabletsPhase 1 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- enzalutamide 40 MG oral capsule [Xtandi]Phase 1 · Prostatic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Nab-paclitaxelPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ORIC-101Phase 1 · Prostatic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- ORIC-101Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ORIC-114 Dose 1 + amivantamabPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ORIC-114 Dose 2 + amivantamabPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ORIC-114 Dose 3 + amivantamabPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ORIC-533Phase 1 · Relapsed or Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- ORIC-944Phase 1 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)PHASE3 · RECRUITING · started Aug 3, 2026ClinicalTrials.gov NCT07723248 · fetched Nov 12, 2026
- ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLCPHASE1 · RECRUITING · started Feb 27, 2025ClinicalTrials.gov NCT06816992 · fetched Nov 12, 2026
- Study of ORIC-944 in Patients With Metastatic Prostate CancerPHASE1 · RECRUITING · started Jun 1, 2022ClinicalTrials.gov NCT05413421 · fetched Nov 12, 2026
- Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationPHASE1_PHASE2 · RECRUITING · started Mar 10, 2022ClinicalTrials.gov NCT05315700 · fetched Nov 12, 2026
- Study of ORIC-533 in Relapsed or Refractory Multiple MyelomaPHASE1 · COMPLETED · started Jan 6, 2022ClinicalTrials.gov NCT05227144 · fetched Nov 12, 2026
- Study of ORIC-101 in Combination With EnzalutamidePHASE1 · TERMINATED · started Oct 28, 2019ClinicalTrials.gov NCT04033328 · fetched Nov 12, 2026
- Study of ORIC-101 in Combination With Anticancer TherapyPHASE1 · TERMINATED · started May 2, 2019ClinicalTrials.gov NCT03928314 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 23, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 23, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 23, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 23, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 8, 2025 · fetched Nov 12, 2026